REBUILD: Exercise Tolerance & Pulmonary Fibrosis Study


Trial Objective

GettyImages-185243058Q.jpgResearchers want to know if inhaled nitric oxide delivered to the lungs will improve exercise tolerance and overall wellbeing of people with pulmonary fibrosis. Participants in the REBUILD study will use an investigational device called INOpulse to inhale nitric oxide every day. They also will wear a wrist monitor to track activity. If needed, transportation to study appointments may be provided.


Active Clinical Trials Closed to Recruitment

Who Can Participate

Patients with pulmonary fibrosis who are receiving oxygen therapy.

Age: 18-80    Gender: Any Gender

Estimated Time Commitment

5 visits over 16 weeks

Payment & Reimbursement  

Payment: Provided

Travel Reimbursement: Available

Trial Contact

For more information, contact:

Jennifer Underwood

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors


Principal Investigators